179 related articles for article (PubMed ID: 11290542)
1. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
Hoos A; Urist MJ; Stojadinovic A; Mastorides S; Dudas ME; Leung DH; Kuo D; Brennan MF; Lewis JJ; Cordon-Cardo C
Am J Pathol; 2001 Apr; 158(4):1245-51. PubMed ID: 11290542
[TBL] [Abstract][Full Text] [Related]
2. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors.
Hoos A; Lewis JJ; Antonescu CR; Dudas ME; Leon L; Woodruff JM; Brennan MF; Cordon-Cardo C
Cancer Res; 2001 Apr; 61(7):3171-5. PubMed ID: 11306504
[TBL] [Abstract][Full Text] [Related]
3. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays.
Gulmann C; Butler D; Kay E; Grace A; Leader M
Histopathology; 2003 Jan; 42(1):70-6. PubMed ID: 12493028
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
5. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer.
Zhang D; Salto-Tellez M; Putti TC; Do E; Koay ES
Mod Pathol; 2003 Jan; 16(1):79-84. PubMed ID: 12527717
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays.
Leversha MA; Fielding P; Watson S; Gosney JR; Field JK
J Pathol; 2003 Aug; 200(5):610-9. PubMed ID: 12898597
[TBL] [Abstract][Full Text] [Related]
7. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
9. Validation of tissue array technology in head and neck squamous cell carcinoma.
Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
[TBL] [Abstract][Full Text] [Related]
10. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
[TBL] [Abstract][Full Text] [Related]
11. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
Jones S; Prasad ML
Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
[TBL] [Abstract][Full Text] [Related]
13. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
15. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
[TBL] [Abstract][Full Text] [Related]
17. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
18. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx.
Griffin MC; Robinson RA; Trask DK
Mod Pathol; 2003 Dec; 16(12):1181-8. PubMed ID: 14681317
[TBL] [Abstract][Full Text] [Related]
19. Design, construction, and analysis of cell line arrays and tissue microarrays for gene expression analysis.
Gately K; Kerr K; O'Byrne K
Methods Mol Biol; 2011; 784():139-53. PubMed ID: 21898218
[TBL] [Abstract][Full Text] [Related]
20. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
Tennstedt P; Köster P; Brüchmann A; Mirlacher M; Haese A; Steuber T; Sauter G; Huland H; Graefen M; Schlomm T; Minner S; Simon R
Int J Oncol; 2012 Jan; 40(1):261-8. PubMed ID: 21956230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
